Skip to content
Strength & muscleResearch article3 min read

How fat in and around muscle may weaken it: a review of sarcopenia mechanisms

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Impact of Adipose Tissue and Lipids on Skeletal Muscle in Sarcopenia. · Journal of cachexia, sarcopenia and muscle · 2025 · Original paper ↗

Key takeaway

This narrative review explains how fat infiltration and lipid metabolites in skeletal muscle can disrupt muscle structure, energy handling and signalling, and so worsen function and performance. It summarises mechanisms from many studies and has no new data or numerical results, so it cannot say how much any intervention helps.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Sarcopenia, loss of muscle mass and function, and sarcopenic obesity are growing concerns in ageing societies, yet approved treatments are limited. The authors summarised how adipose tissue and lipids affect skeletal muscle, hoping to point to prevention and treatment targets.

Who and how

Narrative review of current knowledge about how adipose tissue and lipid metabolites influence skeletal muscle, with mechanistic detail and attention to sarcopenia development, plus future directions. The abstract does not describe a systematic search, number of papers or selection criteria.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Fat infiltration in muscle can change muscle structure, metabolism and signalling, worsening function and physical performance.
  2. 2
    Lipid droplets in muscle cells may matter by size, location and characteristics, not just quantity; lipid metabolites may cause lipotoxicity, with effects varying by type.
  3. 3
    In highly trained athletes, small droplets lie mainly between myofibrils and insulin sensitivity is kept (the athlete's paradox), whereas in type 2 diabetes or obesity larger droplets build up under the cell membrane.
  4. 4
    Ageing and excess nutrients or obesity are tied to mitochondrial dysfunction; SIRT1 and AMPK act through PGC-1α, and adjusting PGC-1α may help protect muscle.
  5. 5
    Muscle and fat communicate through adipokines and myokines; the authors conclude that disordered lipid metabolism and intramuscular fat lead to inflammation, oxidative stress, insulin resistance and reduced muscle mass and strength.

Limits & uncertainty

  1. 1
    As a narrative review, it has no stated search method, so the choice of evidence may be selective.
  2. 2
    Much of the mechanism comes from laboratory and cell-level work, and the abstract does not say how well it holds in people.
  3. 3
    The authors say that more research on fat, lipids and muscle is needed to find the best way to manage sarcopenia.
  4. 4
    This reading is based on the abstract only.

What to take from it

Muscle quality, not just size, seems to matter, and fat inside muscle may be one reason strength declines with age and obesity. This review does not test any treatment, so it supports no specific diet or supplement; discuss concerns about muscle loss with your clinician.

Reading your own data

This is a mechanism review, so there is little in it to track directly. Handy proxies are strength-training progress, grip or chair-stand performance, and body composition from a scale or scan, compared over months under the same conditions.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Although the decline in muscle mass, function and increased visceral obesity are attracting substantial attention in the ageing society, approved treatment modalities for sarcopenia/sarcopenic obesity (SO) remain limited. Elucidating effects and mechanisms of adipose tissue and lipids on skeletal muscle is important for identifying potential prevention and treatment targets for sarcopenia/SO.

Methods

In this narrative review, we aim to comprehensively summarize current knowledge on how adipose tissue and lipid metabolites influence skeletal muscle with detailed mechanistic explanations, especially in sarcopenia development. We also tried to explore future perspectives for optimal strategies for managing sarcopenia.

Results

Fatty infiltration in skeletal muscle can alter the structure, metabolism and signalling pathways of muscle, thereby worsening muscle function and physical performance. Intracellular lipid droplets could disrupt normal physiology within muscle cells, but it might be influenced not only by quantity but also by size, location and characteristics of lipid droplets. Intracellular lipid metabolites may induce lipotoxicity in cell signalling of muscle cells, but effects might differ by types or chemical structure. Highly trained athletes exhibit insulin sensitivity despite high levels of muscular fat, a phenomenon called the athlete's paradox. Lipid droplets within the skeletal muscle of athletes are small and are mainly located in the intermyofibrillar area, which is rich in fast-twitch, Type I fibres. In contrast, patients with Type 2 diabetes/obesity accumulate larger lipid droplets in the subsarcolemmal area, which is richer in Type II fibres. Ageing is intricately associated with mitochondrial dysfunction and the concomitant decline in mitochondrial biogenesis, all of which may lead to sarcopenia. SIRT1 and AMPK, two key energy sensors, are involved in mitochondrial biogenesis through regulation of PGC-1α. Modulation of PGC-1α levels in skeletal muscle may help protect against sarcopenia by preserving muscle integrity, enhancing muscle function, improving insulin sensitivity and reducing inflammation and oxidative stress. Excessive nutrient intake and obesity triggers mitochondrial dysfunction by inducing activation of the inflammatory response and increased production of reactive oxygen species. Skeletal muscle and adipose tissue are closely connected through mediators called adipokines and myokines, and it is important to understand the mechanisms of their interaction.

Conclusions

Dysregulation of lipid metabolism and intramuscular fat accumulation leads to inflammation, oxidative stress, insulin resistance and mitochondrial dysfunction, resulting in reduced muscle mass and strength. Further research on associations between fat/lipids and muscle would be helpful to investigate optimal management strategies for sarcopenia/SO in the rapidly ageing world.

Sources & attribution

Impact of Adipose Tissue and Lipids on Skeletal Muscle in Sarcopenia.

Jang SY, Choi KM.

Journal of cachexia, sarcopenia and muscle · 2025-01-01

DOI: 10.1002/jcsm.70000 ↗PubMed · 40641114 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Overview of reviews

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

In-depth explainersRead study →
·Trial meta-analysis

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

In-depth explainersRead study →
·Observational meta-analysis

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

In-depth explainersRead study →
·Trial meta-analysis

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

In-depth explainersRead study →
Strength & muscle →